tositumomab

Known as: Anti-CD20 Antibody, MoAb Anti-B1, anti-B1 monoclonal antibody 
A monoclonal antibody that is used in the treatment of certain types of non-Hodgkin lymphoma. When tositumomab and iodine I 131 tositumomab (a form… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
PURPOSE Advanced follicular lymphoma (FL) is incurable with conventional chemotherapy and radiotherapy, and optimal front-line… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To evaluate the safety and efficacy of a sequential chemotherapy plus radioimmunotherapy (RIT) regimen in previously… (More)
Is this relevant?
Review
2003
Review
2003
Rituximab, a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20, was the first monoclonal antibody to be… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
CD20-targeted radioimmunotherapy is a promising new treatment for B-cell non-Hodgkin lymphoma (NHL). We now provide updated and… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Relapsed B-cell lymphomas are incurable with conventional chemotherapy and radiation therapy, although a fraction of patients can… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Anti-CD20 monoclonal antibodies have been successfully employed in the clinical treatment of non-Hodgkin's lymphomas in both… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
More than 50% of patients with aggressive B lymphomas and the majority of patients with low grade lymphomas are not cured by… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The B-cell antigen CD20 is expressed on normal B cells and by nearly all B-cell lymphomas. This nonmodulating antigen provides an… (More)
Is this relevant?
Review
1986
Review
1986
Important insights into leukocyte differentiation and the cellular origins of leukemia and lymphoma have been gained through the… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 5
Is this relevant?